Clinical Trial: The Value of Fingerprint Metabolic Profiling in Early Diagnosis and Prognosis Prediction of Patients with Chronic Kidney Disease (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Value of Fingerprint Metabolic Profiling in Early Diagnosis and Prognosis Prediction of Patients with Chronic Kidney Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132987

Registration Time: 2026/09/20

Type: Observational study

Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=296175

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The Value of Fingerprint Metabolic Profiling in Early Diagnosis and Prognosis Prediction of Patients with Chronic Kidney Disease (China)